MapLight Therapeutics
About MapLight Therapeutics
Maplight is a biopharmaceutical company. Maplight discovers and develops novel therapeutics for patients with disorders of the central nervous system (CNS). The company’s work centers on CNS disorders, aiming to bring new treatments to those patients.
Company at a glance
Location
Life at MapLight Therapeutics
Frequently asked questions
Companies similar to MapLight Therapeutics
EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.
Arbio, headquartered in Berlin, Germany, is building an AI-native property management platform for short-term rentals across Europe. It currently manages over 1,000 apartments and operates real properties in Berlin, Hamburg, Vienna, and Leipzig, with plans to expand to additional European cities. The company has raised a $36 million Series A funding and maintains an engineering team of five engineers. Arbio’s platform uses AI to observe, decide, and act on real-world property operations with humans in the loop, enabling AI-assisted management of short-term rental properties across Europe.
The company offers an AI-powered coding assistant for software development. The product is an AI-driven tool designed to assist with coding tasks within software development. By applying artificial intelligence, it supports the coding process. The focus is on AI-powered assistance for software development tasks.



